Literature DB >> 23749489

DNA polymerase β promoter mutations and transcriptional activity in esophageal squamous cell carcinoma.

Min Li1, Wenqiao Zang, Yuanyuan Wang, Yuebai Li, Yunyun Ma, Na Wang, Yue Tang, Lulu Liu, Ziming Dong, Guoqiang Zhao.   

Abstract

The present study analyzed the correlation of DNA polymerase β (DNA polβ) promoter mutations and activity in esophageal squamous cell carcinoma (ESCC). The DNA polβ promoter was amplified from 108 ESCC samples and adjacent paracancerous samples by PCR and cloned into the pGL3-enhancer luciferase vector. The recombined vectors were transfected into esophageal carcinoma cells (EC9706, Eca109, and KYSE30), and luciferase activity was detected using dual luciferase reporter gene technology. Eleven polβ promoter mutations were identified and submitted to GenBank. The mutation rate of the DNA polβ promoter was higher in ESCC tissues (36/108, 33.3 %) than in the paired paracancerous tissues (21/108, 19.4 %) (P = 0.021). The C → A mutation at locus -37 was the hotspot mutation in cancerous tissues, and its frequency was higher in ESCC tissues (26/108) than in paracancerous tissues (7/108) (P = 0.00). The highest relative luciferase activity (RLA) was observed in the DNA polβ promoter, with a C → A mutation at -37. Significant differences in RLA were observed between mutant DNA polβ promoters (except for C detected at -19, T → C at -194, C → A at -37, and T → C at 30) and the wild-type DNA polβ promoter (P = 0.000), and RLA was significantly higher in ESCC tissues than in paracancerous tissues (P = 0.003). Our findings suggest that the upregulation of transcriptional activity induced by mutations in the DNA polβ promoter in ESCC tissues may be one of the molecular mechanisms mediating abnormal overexpression of DNA polβ in ESCC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23749489     DOI: 10.1007/s13277-013-0898-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  20 in total

Review 1.  DNA polymerase beta.

Authors:  Haitham T Idriss; Osama Al-Assar; Samuel H Wilson
Journal:  Int J Biochem Cell Biol       Date:  2002-04       Impact factor: 5.085

2.  Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma.

Authors:  U S Bergerheim; K Kunimi; V P Collins; P Ekman
Journal:  Genes Chromosomes Cancer       Date:  1991-05       Impact factor: 5.006

3.  The overexpression of specialized DNA polymerases in cancer.

Authors:  Mark R Albertella; Alan Lau; Mark J O'Connor
Journal:  DNA Repair (Amst)       Date:  2005-05-02

4.  Mutation of DNA polymerase beta in esophageal carcinoma of different regions.

Authors:  Guo-Qiang Zhao; Tao Wang; Qin Zhao; Hong-Yan Yang; Xiao-Hui Tan; Zi-Ming Dong
Journal:  World J Gastroenterol       Date:  2005-08-14       Impact factor: 5.742

5.  Functional mutation of DNA polymerase beta found in human gastric cancer--inability of the base excision repair in vitro.

Authors:  A Iwanaga; M Ouchida; K Miyazaki; K Hori; T Mukai
Journal:  Mutat Res       Date:  1999-10-22       Impact factor: 2.433

6.  Human beta-polymerase gene. Structure of the 5'-flanking region and active promoter.

Authors:  S G Widen; P Kedar; S H Wilson
Journal:  J Biol Chem       Date:  1988-11-15       Impact factor: 5.157

7.  Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs.

Authors:  Y Canitrot; C Cazaux; M Fréchet; K Bouayadi; C Lesca; B Salles; J S Hoffmann
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

8.  Heterogeneity in expression of DNA polymerase beta and DNA repair activity in human tumor cell lines.

Authors:  Nandan Bhattacharyya; Huan-Chao Chen; Liming Wang; Spira Banerjee
Journal:  Gene Expr       Date:  2002

9.  Deregulated DNA polymerase beta induces chromosome instability and tumorigenesis.

Authors:  Valérie Bergoglio; Marie-Jeanne Pillaire; Magali Lacroix-Triki; Brigitte Raynaud-Messina; Yvan Canitrot; Anne Bieth; Michèle Garès; Michel Wright; Georges Delsol; Lawrence A Loeb; Christophe Cazaux; Jean-Sébastien Hoffmann
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

10.  Overexpression of DNA polymerase beta results in an increased rate of frameshift mutations during base excision repair.

Authors:  Katie Chan; Sue Houlbrook; Qiu-Mei Zhang; Mark Harrison; Ian D Hickson; Grigory L Dianov
Journal:  Mutagenesis       Date:  2007-01-31       Impact factor: 3.000

View more
  7 in total

1.  DNA polymerase β mutations and survival of patients with esophageal squamous cell carcinoma in Linzhou City, China.

Authors:  Min Li; Wenqiao Zang; Yuanyuan Wang; Yunyun Ma; Xiaoyan Xuan; Jimin Zhao; Lulu Liu; Ziming Dong; Guoqiang Zhao
Journal:  Tumour Biol       Date:  2014-01

2.  G648C variant of DNA polymerase β sensitizes esophageal cancer to chemotherapy.

Authors:  Yuanyuan Wang; Qianqian Sun; Wei Guo; Xiaonan Chen; Yuwen Du; Wenqiao Zang; Ziming Dong; Guoqiang Zhao
Journal:  Tumour Biol       Date:  2015-09-03

3.  Enhancement of silencing DNA polymerase β on the radiotherapeutic sensitivity of human esophageal carcinoma cell lines.

Authors:  Yuanyuan Wang; Xiaonan Chen; Xuanyu Hu; Ren Zhang; Yuwen Du; Wenqiao Zang; Ziming Dong; Guoqiang Zhao
Journal:  Tumour Biol       Date:  2014-10

4.  Overexpression of A613T and G462T variants of DNA polymerase β weakens chemotherapy sensitivity in esophageal cancer cell lines.

Authors:  Yuanyuan Wang; Xiaonan Chen; Qianqian Sun; Wenqiao Zang; Min Li; Ziming Dong; Guoqiang Zhao
Journal:  Cancer Cell Int       Date:  2016-11-10       Impact factor: 5.722

5.  Two polymorphic mutations in promoter region of DNA polymerase β in relatively higher percentage of thymic hyperplasia patients.

Authors:  Qingjun Wu; Shan Zhou; Jian Liu; Hongfeng Tong; Yaoguang Sun; Wenxin Tian; Hanbo Yu; Chuan Huang; Donghang Li; Peng Jiao; Chao Ma; Jianping Cai; Dapeng Dai
Journal:  Thorac Cancer       Date:  2020-12-13       Impact factor: 3.500

6.  Polymorphic mutations in the polb gene promoter and their impact on transcriptional activity.

Authors:  Qingjun Wu; Yuying Qi; Shuanghu Wang; Jian Liu; Peiwu Geng; Quan Zhou; Wenqian Zhang; Jianping Cai; Bin Hu; Dapeng Dai; Hui Li
Journal:  Thorac Cancer       Date:  2022-02-06       Impact factor: 3.500

7.  MiR-149 sensitizes esophageal cancer cell lines to cisplatin by targeting DNA polymerase β.

Authors:  Yuanyuan Wang; Jiahui Chen; Man Zhang; Wenwen Zhang; Min Li; Wenqiao Zang; Ziming Dong; Guoqiang Zhao
Journal:  J Cell Mol Med       Date:  2018-05-04       Impact factor: 5.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.